Vivanza Biosciences Limited

VIVANZA6

INE984E01035

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 03/07/2024 BST			5-day change	1st Jan Change
5.01 ^INR	+0.20%		-7.22%	-53.48%

06-11	Vivanza Biosciences Limited Announces Resignation of Girish Bhatt as Non-Executive Director	CI
04-30	Vivanza Biosciences Limited Announces Directors Resignation	CI

Vivanza Biosciences Limited Announces Resignation of Jayendra Mehta as Independent Director

October 06, 2020 at 11:02 am

Vivanza Biosciences Limited announced that resignation of Mr. Jayendra Mehta as Independent Director of the company with effect from October 05, 2020.

Latest news about Vivanza Biosciences Limited

Vivanza Biosciences Limited Announces Resignation of Girish Bhatt as Non-Executive Director	06-11	CI
Vivanza Biosciences Limited Announces Directors Resignation	04-30	CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	04-30	CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-06	CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23	CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023	01/07/23	CI
Vivanza Biosciences Limited Announces Resignation of Manali S. Patel as Independent Director	25/04/23	CI
Vivanza Biosciences Limited Announces Resignation of Girish Bhatt as Managing Director	25/04/23	CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24/01/23	CI
Vivanza Biosciences Bags Contract to Set Up Pharmaceutical Packaging Facility in Sudan	20/01/23	MT
Vivanza Biosciences Limited Announces Receipt of Work Orders Worth Approximately USD 1 Million in Institutional and Industrial Categories	19/01/23	CI
Vivanza Biosciences Shelves Planned Preferential Share Allotment	05/01/23	MT
Vivanza Biosciences Limited cancelled the transaction announced on July 21, 2022	03/01/23	CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	21/07/22	CI
Vivanza Biosciences Limited announced a financing transaction	20/07/22	CI
Vivanza Biosciences Limited Appoints Avinash G. Bhojwani as Company Secretary and Compliance Officer	27/05/22	CI
Vivanza Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	27/05/22	CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	10/02/22	CI
Vivanza Biosciences Limited Announces Change of Designation of Girish Bhatt to Non Executive Director	29/10/21	CI
Vivanza Biosciences Limited Announces Appointment of Hemant Parikh as Chief Executive Officer	29/10/21	CI
Vivanza Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	28/10/21	CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	24/07/21	CI
Vivanza Biosciences : Widens Net Loss in Fiscal Q4	05/07/21	MT
Vivanza Biosciences Limited Announces Resignation of Bhaskar Bhattacharya, Managing Director	03/07/21	CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2021	28/06/21	CI

Chart Vivanza Biosciences Limited

Duration

Period

More charts

Vivanza Biosciences Limited is an India-based specialty pharmaceutical company. The Company offers pharmaceutical products and pharma products. The Company is focused on commercializing generic pharmaceuticals, offering patients accessible medicines. The Company operates in only one that is trading of pharmaceutical product. Its products include gloves and surgical. Gloves products include latex examination gloves powdered, latex surgical powdered, latex free examination gloves-vinyl, latex free examination gloves-nitrile and Latex examination gloves-powdered. The Companyâs products catalogues include Injectable Products, Vivanza Gloves and Therapeutic Index Injection. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VIVANZA BIOSCIENCES LIMITED	-53.48%	2.4M
ELI LILLY AND COMPANY	+54.07%	816B
NOVO NORDISK A/S	+38.59%	634B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	323B
ABBVIE INC.	+5.72%	293B
ASTRAZENECA PLC	+13.40%	238B
ROCHE HOLDING AG	+0.61%	222B
NOVARTIS AG	+13.24%	218B
AMGEN INC.	+7.42%	167B